<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>新浪医药 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2021-01-21T20:42:08+08:00</updated>
  <subtitle>新浪医药新闻为医药行业从业者提供新鲜全面的医药资讯、权威的医药政策专家解读、药企药店医院新药新闻资讯动态，以及畅所欲言的专栏平台。</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>最新54个药品批文！18个一致性申请！奥氮平、右美托咪定、美阿沙坦钾...</title>
    <updated>2021-01-21T17:46:27+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-21:/s/xBKK7OeyWlrrVK-EJsvGgw</id>
    <link href="https://mp.weixin.qq.com/s/xBKK7OeyWlrrVK-EJsvGgw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>布地奈德：变OTC药是好，但隐藏的风险也别忽视</title>
    <updated>2021-01-21T17:46:27+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-21:/s/0RwgvOWf55_Pg4-oIJv9rA</id>
    <link href="https://mp.weixin.qq.com/s/0RwgvOWf55_Pg4-oIJv9rA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>速读社丨百时美施贵宝PD-1抑制剂获优先审评 西南药业盐酸异丙嗪片过评</title>
    <updated>2021-01-21T17:46:27+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-21:/s/VbtYMzoZXwWEUns5Va6umg</id>
    <link href="https://mp.weixin.qq.com/s/VbtYMzoZXwWEUns5Va6umg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>备受关注的新冠防治药物：瑞德西韦2020年销售预期超28亿美元，连花清瘟需求暴增...</title>
    <updated>2021-01-20T17:53:17+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-20:/s/MSm9JPG0vzX7bax2ZKLF_Q</id>
    <link href="https://mp.weixin.qq.com/s/MSm9JPG0vzX7bax2ZKLF_Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>劳而无功！默沙东对吉利德25.4亿美元专利诉讼落败</title>
    <updated>2021-01-20T17:53:17+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-20:/s/nKl4S0q_stV1aWpmQt1u2g</id>
    <link href="https://mp.weixin.qq.com/s/nKl4S0q_stV1aWpmQt1u2g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>速读社丨北京大兴2确诊为境外新冠病毒变异株 拜耳/默沙东心衰新药获批上市</title>
    <updated>2021-01-20T17:53:17+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-20:/s/xeisiHQRKkRgYex_G5VbEg</id>
    <link href="https://mp.weixin.qq.com/s/xeisiHQRKkRgYex_G5VbEg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>牛！A股业绩预增王、2020科创板医药涨幅王……多只新冠试剂概念股疯狂破纪录</title>
    <updated>2021-01-19T17:26:38+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-19:/s/HStrXyaU9khgFvGrIxqhMQ</id>
    <link href="https://mp.weixin.qq.com/s/HStrXyaU9khgFvGrIxqhMQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>国内首个：博雅辑因基因编辑疗法产品ET-01获批进入临床</title>
    <updated>2021-01-19T17:26:38+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-19:/s/0YsamThzw2cBUHHGNryraQ</id>
    <link href="https://mp.weixin.qq.com/s/0YsamThzw2cBUHHGNryraQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>速读社丨​央媒痛批代孕弃养现象 又一家药企阿尔兹海默病研究失败</title>
    <updated>2021-01-19T17:26:38+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-19:/s/F-gCKJsIohVj4l9zw6w1Iw</id>
    <link href="https://mp.weixin.qq.com/s/F-gCKJsIohVj4l9zw6w1Iw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2021年生物技术交易5大趋势</title>
    <updated>2021-01-18T17:32:22+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-18:/s/fFR8NlUJWlMix3la1vvqCg</id>
    <link href="https://mp.weixin.qq.com/s/fFR8NlUJWlMix3la1vvqCg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>临床数据造假：风越大，人越浪，有人获利三千万</title>
    <updated>2021-01-18T17:32:22+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-18:/s/ZxZHBs88YcQTPgYR-AuTMQ</id>
    <link href="https://mp.weixin.qq.com/s/ZxZHBs88YcQTPgYR-AuTMQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>速读社丨赛默飞7.25亿欧元收购Henogen 奥赛康注射用替莫唑胺3类仿制上市申请获批</title>
    <updated>2021-01-18T17:32:22+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-18:/s/Z_rZCgE17Hkov6F3vU4pDw</id>
    <link href="https://mp.weixin.qq.com/s/Z_rZCgE17Hkov6F3vU4pDw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>2021年基因治疗领域面临的5个重要问题！</title>
    <updated>2021-01-17T16:13:28+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-17:/s/wcxSvZQCXKokgOR3snzN7g</id>
    <link href="https://mp.weixin.qq.com/s/wcxSvZQCXKokgOR3snzN7g" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>药品内标签的意义，岂能只是合规？</title>
    <updated>2021-01-17T16:13:28+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-17:/s/-Zw-C4bJcNNnU9PyxRfb3Q</id>
    <link href="https://mp.weixin.qq.com/s/-Zw-C4bJcNNnU9PyxRfb3Q" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>速读社丨“大头娃娃”事件通报：涉事产品含激素；某药企员工感染新冠</title>
    <updated>2021-01-17T16:13:28+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-17:/s/2VQjXjz-BCYugQZrrkxmcA</id>
    <link href="https://mp.weixin.qq.com/s/2VQjXjz-BCYugQZrrkxmcA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>一周药闻丨布罗舒单抗在华获批上市 百济神州PD-1肺鳞癌适应症获批</title>
    <updated>2021-01-15T23:59:14+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-15:/s/m3MGg9F8pehSvIUUjVei6w</id>
    <link href="https://mp.weixin.qq.com/s/m3MGg9F8pehSvIUUjVei6w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>第四批国采2月3日开标！45个品种，涉及百家药企（附目录）</title>
    <updated>2021-01-15T23:59:14+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-15:/s/rA5htJFFeOlLUNLGNK8zpw</id>
    <link href="https://mp.weixin.qq.com/s/rA5htJFFeOlLUNLGNK8zpw" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>盘点2002-2020年获批上市的11个EGFR抑制剂</title>
    <updated>2021-01-15T17:20:36+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-15:/s/0Zjgtvt9BpsjIBhkcEhi8w</id>
    <link href="https://mp.weixin.qq.com/s/0Zjgtvt9BpsjIBhkcEhi8w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>默沙东前研发执行官涉嫌盗取公司大量研究数据</title>
    <updated>2021-01-15T17:20:36+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-15:/s/yWqfztIQVDGdL3ymCaXZYQ</id>
    <link href="https://mp.weixin.qq.com/s/yWqfztIQVDGdL3ymCaXZYQ" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>速读社丨复宏汉霖获得TROP2抗体新药中国区独家权利 贝达药业1类新药BET抑制剂获批临床</title>
    <updated>2021-01-15T17:20:36+08:00</updated>
    <id>tag:mp.weixin.qq.com,2021-01-15:/s/jEU9hFhOLEJDBL6A-v2A7w</id>
    <link href="https://mp.weixin.qq.com/s/jEU9hFhOLEJDBL6A-v2A7w" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>